Veeva Systems Inc Class A VEEV

Morningstar Rating
$273.33 −8.60 (3.05%)
View Full Chart

Company Report

Veeva's Investments in AI Capabilities From Launches and Acquisitions Boost Long-Term Potential

Veeva is the leading provider of cloud-based software solutions tailored to the life sciences industry. It provides an ecosystem of products to address the operating challenges and regulatory requirements that companies in the space face. Instead of focusing on a general, one-size-fits-all system, Veeva has created platforms that are purely designed to serve one industry. And this vertical focus has allowed the company to shape its products for its specific customers to fit their specific needs. Veeva is deeply penetrated in its addressable market, and its continued expanding portfolio of applications presents itself as one of the most attractive offerings in the space.

Price vs Fair Value

VEEV is trading at a LOCK|&bw!#<v premium.
Price
$281.93
Fair Value
?>$
Uncertainty
LOCK|$^
1-Star Price
LOCK|z.^SS
5-Star Price
LOCK|l.x>
Economic Moat
LOCK|Mq>
Capital Allocation
LOCK|h%T@Gq@

Bulls Say, Bears Say

Bulls

Veeva continues to introduce new applications in areas such as safety and clinical operations to service unmet needs, which support our double-digit growth assumptions.

Bears

Moving its CRM from Salesforce’s platform to its Vault Platform could raise concerns for customers and lower its retention rate.

News

Articles & Videos

Trading Information

Previous Close Price
$281.93
Day Range
$272.84–284.59
52-Week Range
$148.05–310.50
Bid/Ask
$272.01 / $276.69
Shares Outstanding
161.91M
Market Cap
$44.25B
Volume/Avg
1M / 2M

Key Statistics

Price/Earnings (Normalized)
32.44
Price/Sales
13.57
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
0.37%

Company Profile

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Mid Core
Total Number of Employees
7,928

Competitors

Valuation

Metric
VEEV
IQV
ORCL
Price/Earnings (Normalized)
32.4420.9117.09
Price/Book Value
6.146.956.75
Price/Sales
13.572.615.65
Price/Cash Flow
28.6616.9413.29
Price/Earnings
VEEV
IQV
ORCL

Financial Strength

Metric
VEEV
IQV
ORCL
Quick Ratio
5.360.621.02
Current Ratio
5.460.711.17
Interest Coverage
—2.995.07
Quick Ratio
VEEV
IQV
ORCL

Profitability

Metric
VEEV
IQV
ORCL
Return on Assets (Normalized)
16.75%7.22%9.91%
Return on Equity (Normalized)
20.35%34.41%63.39%
Return on Invested Capital (Normalized)
20.05%12.37%15.17%
Return on Assets
VEEV
IQV
ORCL

Health Information Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Tempus AI Inc Class A common stock
TEM
—LOCK|>s$14B
Pro Medicus Ltd
PMCUF
—LOCK|kMsd$12B
Pro Medicus Ltd ADR
PMDIY
—LOCK|TJB%$12B
BrightSpring Health Services Inc
BTSG
—LOCK|HHf##$11B
Hinge Health Inc Ordinary Shares - Class A
HNGE
—LOCK|!nh>@$8B
M3 Inc
MTHRF
—LOCK|bpKB$8B
M3 Inc ADR
MTHRY
—LOCK|<L@v%$8B
HealthEquity Inc
HQY
—LOCK|?<F>$7B
Doximity Inc Class A
DOCS
—LOCK|>#$5B

Sponsor Center